A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma Meeting Abstract
| Authors: | Agulnik, M.; Tannir, N. M.; Pressey, J. G.; Gounder, M. M.; Cote, G. M.; Roche, M.; Doleman, S.; Blakemore, S. J.; Clawson, A.; Daigle, S.; Tang, J.; Ho, P. T. C.; Demetri, G. D. |
| Abstract Title: | A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 586s |
| Language: | English |
| ACCESSION: | WOS:000404712500462 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS11071 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS11071 -- Source: Wos |
